P012: Nodular Lymphocyte-predominant Hodgkin Lymphoma a rare disease with good prognosis: a retrospective multicenter experience

P012: Nodular Lymphocyte-predominant Hodgkin Lymphoma a rare disease with good prognosis: a retrospective multicenter experience

Bibliographic Details
Main Authors:	Francesca Pierdomenico, Raquel Marques, Dulcelena Neves, João. Gaião. Santos, Christopher Saunders, Rita Pinho Peixeiro, Marta Henriques, Ana Tome, Daniela Alves, Margarida Badior, Tathiane Lopes, Sonia Leocadio, Marília Gomes, Alexandra Monteiro, Rita Coutinho, Ana Luisa Pinto, Anabela Neves, João. Paulo Fernandes, Maria Gomes Da Silva
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000890616.42207.c9

Similar Items

Nodular lymphocyte-predominant Hodgkin’s lymphoma: Principles of diagnosis and treatment
by: T N Moiseeva, et al.
Published: (2015-11-01)

Nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL): Early outcomes
by: Bhavin Visariya, et al.
Published: (2016-01-01)

THE MORPHOLOGICAL SUBSTRATE AND IMMUNOHYSTOARCHITECTURAL PATTERNS IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA
by: I. A. Shupletsova, et al.
Published: (2019-03-01)

Nodular lymphocyte predominance Hodgkin lymphoma of the parotid gland: a case report
by: Carlos Augusto Ferreira Alves, et al.
Published: (2012-03-01)

Nodular lymphocyte-predominant Hodgkin lymphoma in a patient with Familial Mediterranean Fever
by: Marina Belia, et al.
Published: (2022-06-01)

Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion
by: Adarsh Sidda MD, et al.
Published: (2022-07-01)

Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics
by: Sheren Younes, et al.
Published: (2021-06-01)

Nodular lymphocyte-predominant Hodgkin lymphoma: a rare lymphoma with isolated hepatic presentation
by: Bruno Freitas, et al.
Published: (2023-09-01)

Single center experience in patients with a diagnosis of nodular lymphocyte predominant Hodgkin lymphoma
by: Fahir Özkalemkaş, et al.
Published: (2021-03-01)

Nodular lymphocyte predominant Hodgkin lymphoma and diphenylhydantoin: Report of a case and review of the literature
by: Shobhna Sharma, et al.
Published: (2013-01-01)

Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma
by: Saad Akhtar, et al.
Published: (2021-02-01)

Nodular lymphocyte-predominant hodgkin lymphoma: A rare indolent tumour with recurrence at extranodal sites
by: Rabab, NB, et al.
Published: (2011)

Incidence, histology and immunohistochemistry study of nodular lymphocyte-predominant hodgkin's lymphoma in UMMC (1976-2005)
by: Wan, L.H., et al.
Published: (2007)

Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma
by: Roiya Farhan, MBBS, et al.
Published: (2020-12-01)

When is surgical resection alone appropriate treatment for pediatric nodular lymphocyte-predominant Hodgkin lymphoma?
by: Sarah Y Bessen, et al.
Published: (2021-06-01)

P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)
by: Elena Dorokhina, et al.
Published: (2022-10-01)

P033: Clinical significance of the severity of THRLBCL-like areas in nodular lymphocyte predominant Hodgkin lymphoma
by: Irirna Shupletsova, et al.
Published: (2022-10-01)

Relapsed nodular lymphocyte-predominant Hodgkin lymphoma presenting as severe paraneoplastic hepatitis: a case report
by: Anthony J. Deacon, et al.
Published: (2023-06-01)

Simultaneous occurrence of Kaposi’s sarcoma and nodular lymphocyte predominant subtype of Hodgkin’s lymphoma in the same lymph node
by: Muhit Özcan, et al.
Published: (2009-12-01)

Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy.
by: Abhishek A Solanki, et al.
Published: (2013-01-01)

Transformation and outcome of nodular lymphocyte predominant Hodgkin lymphoma: a Finnish Nationwide population-based study
by: Ilja Kalashnikov, et al.
Published: (2021-12-01)

Two diseases in a single lymph node: nodular lymphocyte predominant hodgkin lymphoma and kaposi's sarcoma
by: E. Turan Erkek, et al.
Published: (2020-10-01)

T014 (0118) MULTICENTRIC ITALIAN EXPERIENCE IN TREATMENT OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL) IN THE RITUXIMAB ERA
Published: (2018-10-01)

P1092: NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL): HISTOLOGYCAL AND CLINICAL REVIEW IN A SINGLE CENTRE.
by: E. Rámila, et al.
Published: (2022-06-01)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
by: Dennis A. Eichenauer, et al.
Published: (2023-06-01)

P076 (0056) CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN‘S LYMPHOMA WITH THRLBCL-LIKE PATTERNS
Published: (2018-10-01)

Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
by: Novella Pugliese, et al.
Published: (2021-04-01)

MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma
by: Alireza Torabi, et al.
Published: (2023-05-01)

Sarcoid like reaction in a child with nodular lymphocytic predominant Hodgkin lymphoma following chemotherapy: A case report
by: Kasi Bharathi Thatikonda, et al.
Published: (2022-01-01)

P077 (0060) COMPARISON IMMUNOARCHITECTURAL PATTERNS OF PRIMARY, EXTRANODAL AND BONE MARROW LESIONS IN NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA
Published: (2018-10-01)

P088: Case series of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Tanzania. A common entity in East Africa?
by: Atukuzwe Kahakwa, et al.
Published: (2022-10-01)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Published: (2018-10-01)

Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report
by: Ryoma Inui, et al.
Published: (2020-09-01)

A woman with visual loss, amenorrhoea and polyuria: the first reported case of nodular lymphocyte-predominant Hodgkin lymphoma presenting with hypopituitarism
by: Matthew Seymour, et al.
Published: (2021-05-01)

P014: Prognostic significance of nutritional indexes (CONUT and PNI) in classical Hodgkin lymphoma patients
by: Rita Costa E. Sousa, et al.
Published: (2022-10-01)

Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
by: Manuel Gotti, et al.
Published: (2023-04-01)

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma
by: Hyung-Chul Park, et al.
Published: (2012-08-01)

Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma
by: Christos Panayi, et al.
Published: (2023-10-01)

Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report
by: Paolo Salvioni Chiabotti, et al.
Published: (2020-09-01)

The stage‐specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score‐matched analysis of the SEER database
by: Shijie Wang, et al.
Published: (2021-01-01)